Report Categories
View AllRecent Articles
View All
GPK Q1 2026 Earnings EPS Beats Estimates by 56 Stock Edges Higher
Atea Pharmaceuticals Q1 2026 Earnings Narrower Loss Beats Expectations Stock Edges Higher
PROV Q1 2026 Earnings EPS Misses Estimates by 336 as Bottom Line Disappoints
AVBC Q1 2026 Earnings EPS Surpasses Estimates Amidst Potential Margin Pressures
CIMP Q1 2026 Earnings Solid EPS Surprise Amid Steady Operating Performance
Versant Media Group Inc VSNT Gains 128 as Shares Test MidRange Resistance
Oxford Lane Capital Notes Edge Lower Remain Within Defined Range OXLCG
Autolus Therapeutics AUTL Gains 268 as Stock Nears Key Resistance Level
MoonLake Immunotherapeutics MLTX Shows Modest Uptick Testing Key Resistance